Who is sponsoring NCT05164796?

NCT05164796 is sponsored by Universita di Verona.

What drugs are being tested in NCT05164796?

Interventions in NCT05164796: IVUS assessment of coronary ostia.

What condition does NCT05164796 study?

NCT05164796 studies Coronary Artery Occlusion.

Is NCT05164796 still recruiting?

NCT05164796 is currently status unknown. Last updated 9 November 2022.

Last reviewed 2022-11-09 · How we verify

NCT05164796: ICARO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IVUS Analysis for Coronary Obstruction in TAVI

Status unknown NA Last updated 9 November 2022

What this trial tests

NA trial testing IVUS assessment of coronary ostia in Coronary Artery Occlusion in 100 participants. Status unknown.

Timeline

20 January 2022

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	Universita di Verona
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	100
Start date	20 January 2022
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	1 location across Italy

Drugs / interventions tested

IVUS assessment of coronary ostia

Conditions studied

Coronary Artery Occlusion — all drugs for Coronary Artery Occlusion →

Sponsor

Universita di Verona — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational, prospective, single-arm and multi-center study to assess the safety and feasibility of IVUS imaging in the setting of TAVI and to describe the angiographic and intravascular ultrasound features in patients with coronary arteries deemed at high-risk for coronary artery obstruction following TAVI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Occlusion

Currently open trials in the same condition.

NCT05705973 — Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients · active not recruiting

Other Universita di Verona trials

Trials by the same sponsor.

NCT07393919 — Discontination of Antidepressants in Remitted Depression · Phase 4 · not yet recruiting
NCT07042724 — Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study · NA · recruiting
NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
NCT07119827 — Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury · recruiting
NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05164796 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universita di Verona
Last refreshed: 9 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05164796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing